Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification
Yan Zhao, Yang Yang, Xiuju Wu, Li Zhang, Xinjiang Cai, Jaden Ji, Sydney Chen, Abigail Vera, Kristina I. Boström, Yucheng Yao
Yan Zhao, Yang Yang, Xiuju Wu, Li Zhang, Xinjiang Cai, Jaden Ji, Sydney Chen, Abigail Vera, Kristina I. Boström, Yucheng Yao
View: Text | PDF
Research Article Cell biology Vascular biology

CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification

  • Text
  • PDF
Abstract

Vascular calcification is a severe complication of cardiovascular diseases. Previous studies demonstrated that endothelial lineage cells transitioned into osteoblast-like cells and contributed to vascular calcification. Here, we found that inhibition of cyclin-dependent kinase (CDK) prevented endothelial lineage cells from transitioning to osteoblast-like cells and reduced vascular calcification. We identified a robust induction of CDK1 in endothelial cells (ECs) in calcified arteries and showed that EC–specific gene deletion of CDK1 decreased the calcification. We found that limiting CDK1 induced E-twenty-six specific sequence variant 2 (ETV2), which was responsible for blocking endothelial lineage cells from undergoing osteoblast differentiation. We also found that inhibition of CDK1 reduced vascular calcification in a diabetic mouse model. Together, the results highlight the importance of CDK1 suppression and suggest CDK1 inhibition as a potential option for treating vascular calcification.

Authors

Yan Zhao, Yang Yang, Xiuju Wu, Li Zhang, Xinjiang Cai, Jaden Ji, Sydney Chen, Abigail Vera, Kristina I. Boström, Yucheng Yao

×

Figure 4

Endothelial deletion of CDK1 prevents aortic endothelial lineage cells from undergoing osteogenic differentiation and reduces aortic calcification.

Options: View larger image (or click on image) Download as PowerPoint
Endothelial deletion of CDK1 prevents aortic endothelial lineage cells f...
(A) Micro-CT imaging of VE-cadherincre/ERT2 Cdk1fl/fl Mgp–/– mice and VE-cadherincre/ERT2 Cdk1fl/fl mice after tamoxifen administration (n = 10). Saline was used as control. Arrow and circles highlight the calcification. Scale bars: 5 mm. (B) Alizarin red staining of descending aortas of VE-cadherincre/ERT2 Cdk1fl/fl Mgp–/– mice and VE-cadherincre/ERT2 Cdk1fl/fl mice after tamoxifen administration (n = 6). Scale bars: 100 μm. (C) Total aortic calcium and expression of Cdk1 and osteogenic and endothelial markers in CD31+CD45– aortic cells isolated from VE-cadherincre/ERT2 Cdk1fl/fl Mgp–/– mice and VE-cadherincre/ERT2 Cdk1fl/fl mice after tamoxifen administration (n = 6). Data in C were analyzed for statistical significance by 1-way ANOVA with Tukey’s multiple-comparison test. The bounds of the boxes are upper and lower quartiles with data points, the line in the box is the median, and whiskers are maximal and minimal values. ***P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts